Pediatric Neurology
Volume 26, Issue 3 , Pages 228-230 , March 2002

Benign intracranial hypertension: atypical presentation of Miller Fisher syndrome?

  • Leena D Mewasingh, MD

      Affiliations

    • Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola, 1020 Brussels, Belgium
    • ,
  • Tayeb Sékhara, MD

      Affiliations

    • Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola, 1020 Brussels, Belgium
    • ,
  • Bernard Dachy, MD

      Affiliations

    • Department of Clinical Neurophysiology, Hôpital Brugmann, 1020 Brussels, Belgium
    • ,
  • Maurice C Djeunang, MD

      Affiliations

    • Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola, 1020 Brussels, Belgium
    • ,
  • Bernard Dan, MD

      Affiliations

    • Corresponding Author InformationCommunications should be addressed to: Prof. Dan; Department of Neurology; Hôpital Universitaire des Enfants Reine Fabiola; 15 Avenue JJ Crocq; 1020 Brussels, Belgium
    • Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola, 1020 Brussels, Belgium

Received 7 June 2001 ,Accepted 4 September 2001.

References 

  1. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med. 1956;255:57–65
  2. Owen BE, Vettaikorumakankav V. Guillain-Barré syndrome. Ped Rev. 1997;18:10–16
  3. Paparounas K, O’Hanlon GM, O’Leary CP, Rowan EG, Willison HJ. Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conducing block in vitro. Brain. 1999;122:807–816
  4. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol. 1992;31:677–679
  5. Winer JB, Hughes RAC, Anderson MJ, Jones DM, Kangro H, Watkins RP. A prospective study of acute idiopathic neuropathy. II antecedents events. J Neurol Neurosurg Psychiatry. 1988;51:613–618
  6. Kuroki S, Saida T, Nukina M, et al.  Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues. Ann Neurol. 1993;33:243–247
  7. Willison HJ, O’hanlon GM. The immunopathogenesis of Miller Fisher syndrome. J Neuroimmunol. 1999;100:3–12
  8. Dandy WE. Intracranial pressure without brain tumor. Diagnosis and treatment. Ann Surg. 1937;106:492–513
  9. Welch K. The intracranial pressure in infants. J Neurosurg. 1980;52:693–699
  10. Soler D, Cox T, Bullock P, Calver DM, Robinson RO. Diagnosis and management of benign intracranial hypertension. Arch Dis Child. 1998;78:89–94
  11. Wang SJ, Silberstein SD, Patterson S, Young WB. Idiopathic intracranial hypertension without papilledema (A case-control study in a headache center). Neurology. 1998;51:245–249
  12. Donaldson JO. Pathogenesis of pseudotumor cerebri syndromes. Neurology. 1981;31:877–880
  13. Malm J, Kristensen B, Markgren P, Ekstedt J. CSF hydrodynamics in idiopathic intracranial hypertension (A long-term study). Neurology. 1992;42:851–858
  14. Denny-Brown DE. The changing pattern of neurologic medicine. N Engl J Med. 1952;246:839–846
  15. Weiss GB, Bajwa ZH, Mehler MF. Co-occurrence of pseudotumor cerebri and Guillain-Barré syndrome in an adult. Neurology. 1991;41:603–604
  16. Peterman AF, Daly PD, Dion FR. Infectious neuronitis (syndrome of Guillain-Barré) in children. Neurology. 1959;9:533–539
  17. Macaya A, Roig M, Fernandez JM, Boronat M. Pseudotumor cerebri, spinal and radicular pain, and hyporeflexia (A clinical variant of the Guillain-Barré syndrome?). Pediatr Neurol. 1988;4:120–121

PII: S0887-8994(01)00362-9

Pediatric Neurology
Volume 26, Issue 3 , Pages 228-230 , March 2002

Article Tools